UNIGE document Scientific Article
previous document  unige:110661  next document
add to browser collection
Title

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

Authors
Strand, Vibeke
Michalska, Margaret
Birchwood, Christine
Pei, Jinglan
Tuckwell, Katie
Finch, Rebecca
Kavanaugh, Arthur
show hidden authors show all authors [1 - 9]
Published in RMD Open. 2017, vol. 3, no. 2, p. e000496
Abstract Two randomised controlled trials, AMBITION (NCT00109408) and ADACTA (NCT01119859), showed tocilizumab (TCZ) monotherapy superior to methotrexate (MTX) and adalimumab (ADA) monotherapy, respectively, for improving rheumatoid arthritis (RA) disease activity. This study compared the benefit of TCZ versus MTX or ADA monotherapy for improving patient-reported outcomes (PROs) in patients with RA.
Identifiers
PMID: 28955499
Full text
Article (Published version) (3 MB) - public document Free access
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
STRAND, Vibeke et al. Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials. In: RMD Open, 2017, vol. 3, n° 2, p. e000496. doi: 10.1136/rmdopen-2017-000496 https://archive-ouverte.unige.ch/unige:110661

226 hits

98 downloads

Update

Deposited on : 2018-11-12

Export document
Format :
Citation style :